SPRO earnings: a negative outcome, -8.4%

On March 23, 2021, Spero Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.4% in the window around the event. It had already run -22.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.